+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Eisai Co - logo

Eisai Limited is a research-based pharmaceutical company that develops, manufactures, and markets healthcare products for patients and their families. It offers products in the areas of Alzheimer's disease, gastrointestinal disorders, epilepsy, cervical dystonia, severe chronic pain, and oncology. The company was founded in 1988 and is based in Hatfield, United Kingdom. It also has operations in the United States, Asia, and Europe.

Malaria Treatment Market Report 2025 - Product Thumbnail Image

Malaria Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Ethical Pharmaceuticals Market Report 2025 - Product Thumbnail Image

Ethical Pharmaceuticals Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Mid-Size Pharmaceuticals Market Report 2025 - Product Thumbnail Image

Mid-Size Pharmaceuticals Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Erythema Market Report and Forecast 2024-2032 - Product Thumbnail Image

Erythema Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 180 Pages
  • Global
From
From
From
From
Vitamin and Minerals Market Report 2025 - Product Thumbnail Image

Vitamin and Minerals Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Toll-Like Receptor Modulators - Pipeline Insight, 2025 - Product Thumbnail Image

Toll-Like Receptor Modulators - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Neem Extract Market Report 2025 - Product Thumbnail Image

Neem Extract Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
From
Crohn's Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Crohn's Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
Vaginal Cancer - Pipeline Review, H2 2020 - Product Thumbnail Image

Vaginal Cancer - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 475 Pages
  • Global
From
From
Loading Indicator